Hyperglycemia and Diabetes in the Posttransplant Patient

Keyphrases

• Diabetes 100%
• Hyperglycemia 100%
• Glycemic Control 100%
• Glucose Level 100%
• Glucose-lowering Drugs 100%
• Surgical Patients 50%
• High Risk 50%
• Clinical Course 50%
• Low Risk 50%
• Insulin Resistance 50%
• Paucity 50%
• Immunosuppressive Agents 50%
• Hospital Course 50%
• Low Mortality 50%
• Graft Outcome 50%
• Hypoglycemia 50%
• Complex Interplay 50%
• Infection Risk 50%
• Non-insulin 50%
• Insulin Dose 50%
• Counterregulatory Hormones 50%
• Nontransplant 50%
• End Organ Failure 50%
• Postoperative Pain 50%
• Targeted Management 50%
• Dipeptidyl peptidase-4 (DPP-4) 50%
• Glucagon-like peptide-1 Receptor (GLP-1R) 50%
• Acute Hyperglycemia 50%
• Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 50%
• Glucose Targets 50%
• Blood Glucose Metabolism 50%
• Fluctuating Glucose 50%

Medicine and Dentistry

• Diabetes 100%
• Hyperglycemia 100%
• Glycemic Control 100%
• Infection 50%
• Disease Course 50%
• Immunosuppressive Drug 50%
• Glucose Metabolism 50%
• Insulin Resistance 50%
• Hypoglycemia 50%
• Blood Glucose 50%
• Postoperative Pain 50%
• Sodium Glucose Cotransporter 2 Inhibitor 50%
• Counterregulatory Hormones 50%